Oral cancer: molecular, cellular and immunological mechanisms

ISRCTN ISRCTN71267356
DOI https://doi.org/10.1186/ISRCTN71267356
Secondary identifying numbers 8130
Submission date
30/03/2010
Registration date
09/06/2010
Last edited
25/06/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

http://www.cancerhelp.org.uk/trials/a-study-to-learn-more-about-causes-mouth-cancer

Contact information

Dr Karwan Moutasim
Scientific

Cancer Sciences Building
Mailpoint 824, Tremona Road
Southampton
SO16 6YD
United Kingdom

Study information

Study designNon-randomised observational clinical laboratory study
Primary study designObservational
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleInvestigation of the molecular mechanisms promoting oral cancer development and progression
Study hypothesisOral cancer (OSCC) is the 8th most common cancer worldwide, representing about 4% of all malignancies. In the UK, the incidence has increased dramatically over the last 20 years, particularly in young non-smokers, with around 5,000 new cases each year. Compared with many cancers, OSCC remains a relatively understudied disease. And despite advances in surgery and radiotherapy, which remain the standard treatment options, the mortality rate has remained unchanged for decades, with a 5-year survival rate of around 50%.

Oral cancer may be preceded by a premalignant, histologically dysplastic lesion, usually presenting clinically as a white or red patch in the mouth. However, only around 10 - 15% of patients diagnosed with oral dysplasia will develop oral cancer.
Ethics approval(s)Isle of Wight, Portsmouth and South East Hampshire Research Ethics Committee, 11/01/2010, ref: 09/H0501/90
ConditionTopic: National Cancer Research Network; Subtopic: Head and Neck Cancer; Disease: Head and Neck
Intervention1. Surgical biopsy
2. Venesection

Study entry: registration only
Intervention typeOther
Primary outcome measureTo gain an increased understanding of the cellular and molecular biology of oral/oropharyngeal cancer. This will involve identifying biomarkers which may predict patient prognosis and/or response to treatment.
Secondary outcome measuresNo secondary outcome measures
Overall study start date05/04/2010
Overall study end date20/03/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned sample size: 500
Participant inclusion criteria1. Clinical suspicion of premalignant oral/oropharyngeal lesion and/or condition
2. Clinical and histopathologic diagnosis of oral/oropharyngeal cancer
3. Male and female, lower age limit of 18 years
Participant exclusion criteriaDoes not meet inclusion criteria
Recruitment start date05/04/2010
Recruitment end date20/03/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Cancer Sciences Building
Southampton
SO16 6YD
United Kingdom

Sponsor information

Southampton University Hospitals NHS Trust (UK)
Hospital/treatment centre

Tremona Road
Southampton
SO16 6YD
England
United Kingdom

Website http://www.soton.ac.uk/
ROR logo "ROR" https://ror.org/0485axj58

Funders

Funder type

Charity

British Association of Oral and Maxillofacial Surgeons (UK)

No information available

Cancer Research UK (CRUK) (UK) (ref: 507862102)
Private sector organisation / Other non-profit organizations
Alternative name(s)
CR_UK, Cancer Research UK - London, CRUK
Location
United Kingdom
The Health Foundation (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

25/06/2020: No publications found.
18/11/2016: No publications found in PubMed, verifying study status with principal investigator.